182 related articles for article (PubMed ID: 16799160)
1. Intracellular killing of Brucella melitensis in human macrophages with microsphere-encapsulated gentamicin.
Lecároz C; Blanco-Prieto MJ; Burrell MA; Gamazo C
J Antimicrob Chemother; 2006 Sep; 58(3):549-56. PubMed ID: 16799160
[TBL] [Abstract][Full Text] [Related]
2. Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes.
Prior S; Gander B; Lecároz C; Irache JM; Gamazo C
J Antimicrob Chemother; 2004 Jun; 53(6):981-8. PubMed ID: 15102748
[TBL] [Abstract][Full Text] [Related]
3. Poly(D,L-lactide-coglycolide) particles containing gentamicin: pharmacokinetics and pharmacodynamics in Brucella melitensis-infected mice.
Lecaroz MC; Blanco-Prieto MJ; Campanero MA; Salman H; Gamazo C
Antimicrob Agents Chemother; 2007 Apr; 51(4):1185-90. PubMed ID: 17220415
[TBL] [Abstract][Full Text] [Related]
4. Nanocarriers with gentamicin to treat intracellular pathogens.
Lecaroz C; Gamazo C; Blanco-Prieto MJ
J Nanosci Nanotechnol; 2006; 6(9-10):3296-302. PubMed ID: 17048550
[TBL] [Abstract][Full Text] [Related]
5. Novel bioactive hydrophobic gentamicin carriers for the treatment of intracellular bacterial infections.
Imbuluzqueta E; Elizondo E; Gamazo C; Moreno-Calvo E; Veciana J; Ventosa N; Blanco-Prieto MJ
Acta Biomater; 2011 Apr; 7(4):1599-608. PubMed ID: 21115143
[TBL] [Abstract][Full Text] [Related]
6. Hydrophobic gentamicin-loaded nanoparticles are effective against Brucella melitensis infection in mice.
Imbuluzqueta E; Gamazo C; Lana H; Campanero MÁ; Salas D; Gil AG; Elizondo E; Ventosa N; Veciana J; Blanco-Prieto MJ
Antimicrob Agents Chemother; 2013 Jul; 57(7):3326-33. PubMed ID: 23650167
[TBL] [Abstract][Full Text] [Related]
7. Gentamicin-loaded microspheres for treatment of experimental Brucella abortus infection in mice.
Prior S; Gander B; Irache JM; Gamazo C
J Antimicrob Chemother; 2005 Jun; 55(6):1032-6. PubMed ID: 15883176
[TBL] [Abstract][Full Text] [Related]
8. Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity.
Jeong YI; Na HS; Seo DH; Kim DG; Lee HC; Jang MK; Na SK; Roh SH; Kim SI; Nah JW
Int J Pharm; 2008 Mar; 352(1-2):317-23. PubMed ID: 18160236
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable micro- and nanoparticles as long-term delivery vehicles for gentamicin.
Lecaroz C; Gamazo C; Renedo MJ; Blanco-Prieto MJ
J Microencapsul; 2006 Nov; 23(7):782-92. PubMed ID: 17123922
[TBL] [Abstract][Full Text] [Related]
10. In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres.
Prior S; Gander B; Blarer N; Merkle HP; Subirá ML; Irache JM; Gamazo C
Eur J Pharm Sci; 2002 Mar; 15(2):197-207. PubMed ID: 11849917
[TBL] [Abstract][Full Text] [Related]
11. Phagocytic activity of alveolar macrophages toward polystyrene latex microspheres and PLGA microspheres loaded with anti-tuberculosis agent.
Hasegawa T; Hirota K; Tomoda K; Ito F; Inagawa H; Kochi C; Soma G; Makino K; Terada H
Colloids Surf B Biointerfaces; 2007 Nov; 60(2):221-8. PubMed ID: 17683920
[TBL] [Abstract][Full Text] [Related]
12. Improvement of gentamicin poly(D,L-lactic-co-glycolic acid) microspheres for treatment of osteomyelitis induced by orthopedic procedures.
Virto MR; Elorza B; Torrado S; Elorza Mde L; Frutos G
Biomaterials; 2007 Feb; 28(5):877-85. PubMed ID: 17064761
[TBL] [Abstract][Full Text] [Related]
13. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections.
Prior S; Gamazo C; Irache JM; Merkle HP; Gander B
Int J Pharm; 2000 Feb; 196(1):115-25. PubMed ID: 10675713
[TBL] [Abstract][Full Text] [Related]
14. Sterilization of gentamicin containing collagen/PLGA microparticle composites.
Friess W; Schlapp M
Eur J Pharm Biopharm; 2006 Jun; 63(2):176-87. PubMed ID: 16497493
[TBL] [Abstract][Full Text] [Related]
15. Effect of lactide/glycolide monomers on release behaviors of gentamicin sulfate-loaded PLGA discs.
Yoo JY; Kim JM; Khang G; Kim MS; Cho SH; Lee HB; Kim YS
Int J Pharm; 2004 May; 276(1-2):1-9. PubMed ID: 15113609
[TBL] [Abstract][Full Text] [Related]
16. Amoxicillin-bearing microparticles: potential in the treatment of Listeria monocytogenes infection in Swiss albino mice.
Farazuddin M; Chauhan A; Khan RM; Owais M
Biosci Rep; 2011 Aug; 31(4):265-72. PubMed ID: 20687896
[TBL] [Abstract][Full Text] [Related]
17. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
Ohashi K; Kabasawa T; Ozeki T; Okada H
J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
[TBL] [Abstract][Full Text] [Related]
18. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
[TBL] [Abstract][Full Text] [Related]
19. Phagocytosis of PLGA microparticles in rat peritoneal exudate cells: a time-dependent study.
de Jesus Gomes A; Lunardi CN; Caetano FH; Lunardi LO; da Hora Machado AE
Microsc Microanal; 2006 Oct; 12(5):399-405. PubMed ID: 16984666
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Brucella melitensis infection in mice by use of liposome-encapsulated gentamicin.
Hernández-Caselles T; Vera A; Crespo F; Villalaín J; Gómez-Fernández JC
Am J Vet Res; 1989 Sep; 50(9):1486-8. PubMed ID: 2802318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
